A Phase II Prospective, Randomized, Multi-Center, Diabetic Macular Edema Dose Ranging, Comparator Study Evaluating the Efficacy and Safety of PF-04523655 Versus Laser Therapy (DEGAS).
Phase of Trial: Phase II
Latest Information Update: 05 Mar 2018
At a glance
- Drugs PF 4523655 (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- Acronyms DEGAS
- 17 Apr 2013 Status changed from completed to discontinued.
- 15 Jan 2011 Additional lead trial centre/investigator identified as reported by ClinicalTrials.gov.
- 15 Jan 2011 New source identified and integrated (Clinical Trials Registry - India).
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History